New Peer-Reviewed Study Validates Paradigm Health Products

Got story updates? Submit your updates here. ›

New peer-reviewed research has validated the effectiveness of products from Paradigm Health, a leading provider of study conduct solutions. The research, published in a prominent medical journal, found that Paradigm Health's products significantly improved the quality and efficiency of clinical trials across a range of therapeutic areas.

Why it matters

This independent validation from a respected peer-reviewed source is a major milestone for Paradigm Health, a fast-growing startup in the highly competitive clinical trials technology space. The findings could help Paradigm Health attract new clients and drive further adoption of its innovative products among pharmaceutical companies and research organizations.

The details

The study, conducted by researchers at a leading university, evaluated the performance of Paradigm Health's suite of study conduct tools over the course of several large-scale clinical trials. The results showed that Paradigm Health's products led to measurable improvements in areas such as participant recruitment, data quality, and protocol adherence compared to traditional methods.

• The research was published on April 8, 2026.

What’s next

Paradigm Health plans to highlight the new research findings in its marketing materials and sales pitches as it continues to expand its customer base among pharmaceutical companies and contract research organizations.